HP rejects Xerox's raised takeover offer of $35 billion

(Reuters) - HP Inc (NYSE: HPQ) on Thursday rejected Xerox Holdings Corp's (NYSE: XRX) raised takeover bid of about $35 billion, saying it undervalued the personal computer maker.

The U.S. printer maker last month increased its offer by $2 to $24 per share, after its previous buyout offers were rejected by the PC maker for the same reason.

Chip Bergh, chair of HP's board, said the offer would leave shareholders with an investment in a combined company that is burdened with an irresponsible level of debt.

"(It) would subsequently require unrealistic, unachievable synergies that would jeopardize the entire company," Bergh said in a statement.

He pointed to declining sales at Xerox and said its recent sale of its interest in the Fuji-Xerox joint venture raised concerns about the company's future position.

Xerox decided https://www.reuters.com/article/us-xerox-fujifilm/xerox-exits-fujifilm-venture-with-2-3-billion-stake-sale-to-japan-partner-idUSKBN1XF0NB to sell its 25% stake in Fuji Xerox, its joint venture with Fujifilm Holdings <4901.T>, for $2.3 billion in November last year, following investor activism that scuppered a deal between the two companies.

After Xerox raised its bid last month, HP said it would implement a poison pill plan to stop investors from amassing more than 20% stake in the company.

HP on Thursday requested shareholders to reject Xerox's tender offer launched earlier this week, saying it would disproportionately benefit Xerox shareholders relative to HP shareholders.

Xerox shares fell over 4% and HP shares about 1% in early trading.

(Reporting by Akanksha Rana in Bengaluru; Editing by Vinay Dwivedi and Arun Koyyur)

---

Serious News for Serious Traders! Try StreetInsider.com Premium Free!

---

You May Also Be Interested In

• Humana surges: Barclays bets big on Medicare star ratings rebound
• Nektar Therapeutics stock rises on $90M jury verdict vs Lilly
• Star Fashion Culture stock falls on $9.6M share offering